More children survive neuroblastoma

November 18, 2019

Both the survival rate and the incidence of neuroblastoma have increased in the last decennia, as was shown by a study from the Princess Máxima Center. The improved chance of survival and the increase in the number of patients has been greatest in the high risk group; children older than 18 months with a stage 4 neuroblastoma.

In the early nineties, 6 percent of the children with high risk neuroblastoma survived five years after diagnosis. Nowadays, 43 percent survives. 'The prognosis for the high risk has improved most significantly', says Michelle Tas. Together with her colleague Ardine Reedijk, she performed the study and wrote the article that was published in the scientific journal European Journal of Cancer. The study shows that the introduction of a high dose of chemotherapy followed by autologous stem cell transplantation and immunotherapy were responsible for the increased survival rate.

For this study, the research team used data from the Dutch Cancer Registry (NKR) which are collected nationwide since 1990. Besides the improved prognosis the researchers found that more children were diagnosed with neuroblastoma in the last decennia. In 1990-1994, twenty patients were diagnosed per year. In 2010-2014 this increased to 26. 'The increase is most prominent in the same high risk group of children above 18 months with a stage 4 neuroblastoma', says Max van Noesel, MD, PhD.

The increased incidence remains unexplained, so far. Conceivable influences, such as modern diagnostic tools and improved registration of tumors, were incorporated in the analysis. However, none of them explained the increase. 'That is very frustrating', says Tas, 'It seems possible that the Western lifestyle or environmental factors contributed to the increased incidence, these have changed with time. However, we don't have an indication which factors play a role.'

'Fortunately, the outcome is positive in the end - more children survive this disease', stated Van Noesel, 'that is the result of many (inter)national investments of oncologists and researchers in researching new treatment methods and adjusting the treatment strategies.'
-end-
Read here the full article: https://doi.org/10.1016/j.ejca.2019.09.025

Co-authors: M.L. Tas* and A.M.J. Reedijk*. H.E. Karim-Kos, L.C.M. Kremer, C.P. van de Ven, M.P. Dierselhuis, N.K.A. van Eijkelenburg, M. van Grotel, K.C.J. Kraal, A.M.L. Peek, J.W.W. Coebergh, G.O.R. Janssens, B. de Keizer, R.R. de Krijger, R. Pieters. G.A.M. Tytgat*, and M.M. van Noesel*

Funding: This work was supported by Stichting Kinderen Kankervrij (KiKa) and Villa Joep.

Princess Máxima Center for Pediatric Oncology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.